Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | 0.00% | -8.20% | -15.79% |
May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.79% | 35.01M | |
-39.00% | 3.01B | |
+22.02% | 1.94B | |
-0.62% | 1.66B | |
+35.75% | 1.34B | |
-16.17% | 965M | |
-22.01% | 895M | |
+6.77% | 827M | |
-23.80% | 638M | |
+9.43% | 516M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Earnings Flash (CODX) CO-DIAGNOSTICS Reports Q3 Revenue $5.1M